Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

HRT 'reduces risk of heart attack'

  • Comment

Taking hormone replacement therapy (HRT) during the menopause can reduce the risk of heart failure and heart attacks, a study suggests.

And researchers said that taking HRT is not associated with an increased risk of cancer or strokes.

HRT, which is used to relieve symptoms of the menopause, is a hotly debated subject between academics. Previous research indicated that taking the drugs could lead to an increased risk of breast cancer and there were growing concerns that it could be linked to heart disease and stroke.

But this new research lends support to the use of the drugs.

Researchers in Denmark examined 1,000 women who began the study when they were aged between 45 and 58. Half of the group were given HRT which was started early after the menopause and the control group received no treatment.

The study, published on, found that after 10 years, 33 women in the control group had died or suffered heart failure or a heart attack compared with just 16 women who were given HRT.

They also found that 36 women in the HRT group were treated for cancer compared with 39 in the control group - 10 women in the HRT group were treated for breast cancer compared with 17 in the control group.

Eleven women in the HRT group were treated for stroke compared with 14 in the control group.

The health benefits noted by the researchers occurred 10 years after the women started taking HRT and continued for six years afterwards, they said.

“Our findings suggest that initiation of hormone replacement therapy in women early after menopause significantly reduces the risk of the combined endpoint of mortality, myocardial infarction, or heart failure,” the authors conclude.

“Importantly, early initiation and prolonged hormone replacement therapy did not result in an increased risk of breast cancer or stroke.”

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.